Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Follicular Lymphoma: Evolving Treatment Landscape

EP. 1: Diagnosis and Prognosis of Follicular Lymphoma

January 18th 2019

EP. 2: Risk Assessment in Follicular Lymphoma

January 18th 2019

EP. 3: Up-Front Therapy in Follicular Lymphoma

January 18th 2019

EP. 4: Treatment Options for High-Risk Follicular Lymphoma Cases

January 18th 2019

EP. 5: Maintenance Therapy and MRD Testing in Follicular Lymphoma

January 18th 2019

EP. 6: Treating Relapsed or Refractory Follicular Lymphoma

January 18th 2019

EP. 7: Third-Line Treatments and Transplantation

January 18th 2019

EP. 8: Use of PI3K Inhibitors in Relapsed Follicular Lymphoma

January 18th 2019

EP. 9: Long-Term Efficacy and Safety of Copanlisib

January 18th 2019

EP. 10: Strategies for Therapeutic Sequencing Agents

January 18th 2019

EP. 11: Potential of R2 Regimen in Treating Follicular Lymphoma

January 18th 2019

EP. 12: Immunotherapeutic Agents Against Follicular Lymphoma

January 18th 2019

EP. 13: Emerging Therapies and Combinations

January 18th 2019

EP. 14: Cause for Optimism in Follicular Lymphoma Treatment

January 18th 2019
Advertisement
Advertisement

Trending on OncLive

1

ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC

2

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

3

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

4

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

5

FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us